Mogamulizumab for the treatment of T-cell lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2017.1347634
Abstract: ABSTRACT Introduction: T-cell lymphoma is a relatively rare hematologic malignancy that accounts for 10–20% of non-Hodgkin lymphomas. Treatment strategies for T-cell lymphomas are different from that for B-cell lymphomas and have poor prognoses. Among various… read more here.
Keywords: ccr4 positive; positive cell; treatment; cell lymphomas ... See more keywords